BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 28327451)

  • 1. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
    Li Y; Zhong X; Cheng G; Zhao C; Zhang L; Hong Y; Wan Q; He R; Wang Z
    Atherosclerosis; 2017 Apr; 259():75-82. PubMed ID: 28327451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response association between C-reactive protein and risk of all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies.
    Ni P; Yu M; Zhang R; Cheng C; He M; Wang H; Chen S; Duan G
    Ann Epidemiol; 2020 Nov; 51():20-27.e11. PubMed ID: 32702432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
    Parrinello CM; Lutsey PL; Ballantyne CM; Folsom AR; Pankow JS; Selvin E
    Am Heart J; 2015 Aug; 170(2):380-9. PubMed ID: 26299237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hs-CRP in stroke: A meta-analysis.
    Zhou Y; Han W; Gong D; Man C; Fan Y
    Clin Chim Acta; 2016 Jan; 453():21-7. PubMed ID: 26633855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of lipoprotein(a) and high-sensitivity C-reactive protein on the risk of all-cause and cardiovascular death in patients with acute myocardial infarction: a large prospective cohort study.
    Wang Z; Tang J; Shi Q; Fang L; Liu N; Zhang J
    Front Endocrinol (Lausanne); 2024; 15():1392859. PubMed ID: 38812817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between high sensitivity C-Reactive protein and prevalence of asymptomatic carotid artery stenosis.
    Huang X; Wang A; Liu X; Chen S; Zhu Y; Liu Y; Huang K; Wu J; Chen S; Wu S; Zhao X
    Atherosclerosis; 2016 Mar; 246():44-9. PubMed ID: 26752692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive value of interleukin-6 and C-reactive protein in risk prediction for all-cause and cardiovascular mortality among a representative adult cohort in Taiwan.
    Lin YH; Glei D; Weinstein M; Wu SI; Chien KL
    J Formos Med Assoc; 2017 Dec; 116(12):982-992. PubMed ID: 28292623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein for predicting cardiovascular and all-cause mortality in type 2 diabetic patients: A meta-analysis.
    Tian R; Tian M; Wang L; Qian H; Zhang S; Pang H; Liu Z; Fang L; Shen Z
    Cytokine; 2019 May; 117():59-64. PubMed ID: 30826600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating interleukin-6 levels and cardiovascular and all-cause mortality in the elderly population: A meta-analysis.
    Li H; Liu W; Xie J
    Arch Gerontol Geriatr; 2017 Nov; 73():257-262. PubMed ID: 28866452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
    Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
    Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein: adjunct to cardiovascular risk assessment.
    Bahadursingh S; Beharry K; Maharaj K; Mootoo C; Sharma P; Singh J; Teelucksingh K; Tilluckdharry R
    West Indian Med J; 2009 Dec; 58(6):551-5. PubMed ID: 20583681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRP level and HDL cholesterol concentration jointly predict mortality in a Korean population.
    Kim KI; Oh SW; Ahn S; Heo NJ; Kim S; Chin HJ; Na KY; Chae DW; Kim CH; Kim S
    Am J Med; 2012 Aug; 125(8):787-95.e4. PubMed ID: 22840665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies.
    Peng HY; Man CF; Xu J; Fan Y
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):78-86. PubMed ID: 25559959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department: a retrospective cohort study.
    Yoshinaga R; Doi Y; Ayukawa K; Ishikawa S
    BMJ Open; 2017 Oct; 7(10):e015112. PubMed ID: 28988163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity C-reactive protein levels and cancer mortality.
    Ko YJ; Kwon YM; Kim KH; Choi HC; Chun SH; Yoon HJ; Goh E; Cho B; Park M
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2076-86. PubMed ID: 23136255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
    Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Predictive Value of High-Sensitivity C-Reactive Protein for Cancer Mortality in Patients Undergoing Percutaneous Coronary Intervention.
    Endo H; Dohi T; Funamizu T; Shitara J; Wada H; Doi S; Naito R; Konishi H; Ogita M; Iwata H; Kasai T; Okazaki S; Isoda K; Shimada K; Miyauchi K; Daida H
    Circ J; 2019 Feb; 83(3):630-636. PubMed ID: 30541988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.